For patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine did not significantly improve the duration of survival and free of vasopressor administration over 7 days.
Sepsis incidence and mortality decreased from 1990 to 2017, but there was considerable regional variation.
From 2003 to 2014, sepsis-associated mortality rates significantly declined in patients with cancer, yet these rates have remained relatively unchanged in patients without cancer.
Researchers sought to assess long-term effects of a primary care management intervention on outcomes of sepsis survivors.
Vanco Ready, a ready-to-use (RTU) vancomycin injection, has been made available by Xellia Pharmaceuticals.
System-wide implementation presents opportunity to improve care for patients who may have sepsis.
Early fluid resuscitative efforts are important in patients with sepsis with cirrhosis, congestive heart failure, or end-stage renal disease to prevent acute respiratory failure.
In this study, we found that early first antibiotic administration was associated with improved outcomes in ED patients with septic shock using propensity score analysis.
In-hospital mortality was reduced among patients who received the severe sepsis/septic shock treatment bundle.
Among patients with septic shock who receive norepinephrine, the administration of selepressin compared with placebo was not associated with an improvement in vasopressor-free and ventilator-free days.
